Jones Financial Companies
IOVA icon

Jones Financial Companies’s Iovance Biotherapeutics IOVA Stock Holding History

Jones Financial Companies’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.6K Buy
14,026
+2,340
+20% +$8.89K ﹤0.01% 3047
2026
Q1 		$41K Buy
11,686
+1,345
+13% +$4.3K ﹤0.01% 3016
2025
Q4 		$28.2K Buy
10,341
+5,100
+97% +$11.8K ﹤0.01% 2793
2025
Q3 		$11.1K Buy
5,241
+2,390
+84% +$5.64K ﹤0.01% 3041
2025
Q2 		$4.82K Buy
2,851
+375
+15% +$933 ﹤0.01% 3143
2025
Q1 		$8.81K Buy
2,476
+905
+58% +$4.67K ﹤0.01% 2763
2024
Q4 		$11.6K Buy
1,571
+310
+25% +$2.87K ﹤0.01% 2467
2024
Q3 		$12.1K Buy
1,261
+1,080
+597% +$10.2K ﹤0.01% 2153
2024
Q2 		$1.45K Buy
+181
New +$1.94K ﹤0.01% 2221

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Jones Financial Companies's IOVA Position: Q2 2026 in Review

Jones Financial Companies increased its Iovance Biotherapeutics (IOVA) stake by 20% in Q2 2026, buying an estimated $8.89K and bringing the position to 14,026 shares worth $59.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3047.

Jones Financial Companies first reported a position in IOVA in Q2 2024 and has held it in 9 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Jones Financial Companies held 14,026 shares of Iovance Biotherapeutics worth $59.6K as of Q2 2026.
  • Jones Financial Companies bought 2,340 Iovance Biotherapeutics shares in Q2 2026, an estimated $8.89K.
  • Iovance Biotherapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3047 holding.
  • Jones Financial Companies first reported a position in Iovance Biotherapeutics in Q2 2024 and has held it in 9 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.